Company Filing History:
1 out of 4,304 
1 out of 1 Years Active: 2025
Title: Bang-Chieh Huang: Innovator in COVID-19 Treatment
Introduction
Bang-Chieh Huang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the fight against COVID-19. His innovative approach has led to the development of a unique method for treating SARS-CoV2-related diseases.
Latest Patents
Huang holds a patent for a method and combination for the suppression of the COVID-19 virus. This patent outlines a method for treating a SARS-CoV2 3CL-related disease by blocking the dimerization of the 3C-like main protease (3CL) of the SARS-CoV2 virus. The method involves administering a first agent that binds to a first binding site of the SARS-CoV2 3CL complex and a second agent that binds to a second binding site, which are functionally different sites in the three-dimensional structure of the complex. This pharmaceutical combination aims to suppress SARS-CoV2, thereby alleviating COVID-19.
Career Highlights
Throughout his career, Huang has worked with esteemed institutions such as Tsinghua University and Praexisio Taiwan, Inc. His work has been instrumental in advancing research and development in the medical field.
Collaborations
Huang has collaborated with notable colleagues, including Lee-Wei Yang and Kun-Lin Tsai. These partnerships have contributed to the success of his innovative projects.
Conclusion
Bang-Chieh Huang's contributions to the treatment of COVID-19 through his patented method highlight his role as a significant inventor in the medical field. His work continues to impact the fight against viral diseases, showcasing the importance of innovation in healthcare.